Kidney transplant drug boosts immune activity in breast cancer Oncology Nurse Advisor The immunosuppressant agent daclizumab, which is used to prevent acute organ rejection in persons undergoing renal transplants, has now been shown to improve survival by 30% in patients with breast cancer who received a therapeutic vaccine. |
